Whether you love them or you hate them, penny stocks are contentious. These tickers trading for less than $5 per share have earned …
Genocea Biosciences announced that the US Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for its GEN-011 cancer immunotherapy, …
Genocea Biosciences Inc (NASDAQ:GNCA) shares are shooting up 25% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?
Shares of Genocea Biosciences Inc (NASDAQ:GNCA) rose nearly 17% in after-hours trading Monday after analysts at Cantor started covering the stock, rating it …
James “Jim” Flynn first walked onto the Deerfield Management team seventeen years ago, since a firm that cares about strides in the healthcare …
A tale of two beaten biotech stocks: GNCA, AXON.
Healthcare analysts share two cents on two falling biotech stocks.
Genocea shares are plunging on termination of genital herpes treatment GEN-003.
Genocea Biosciences Inc (NASDAQ:GNCA) shares were plummeting almost 15% yesterday after the biotech firm and are another 5% dive today after a lackluster …
Cowen analyst Phil Nadeau is out with a bullish note on shares of Genocea Biosciences Inc (NASDAQ:GNCA), reiterating an Outperform rating with a $40 price …